摘要
目的:评价盐酸达泊西汀联合小剂量他达拉非治疗原发性早泄(PE)的临床疗效。方法:收集原发性PE患者97例,随机分成对照组(n=46)和治疗组(n=51),对照组性交前按需口服盐酸达泊西汀30mg;治疗组性交前按需口服盐酸达泊西汀片30mg,同时每日服用(OAD)小剂量他达拉非片5mg,疗程12周。嘱患者在治疗期间规律性生活,每月性生活≥4次,治疗前后行中国早泄患者性功能评价表5(CIPE-5)评分及阴道内射精潜伏期(IELT)测评并做好相关记录。结果:与治疗前比较,治疗后两组CIPE-5评分及IELT均明显提高,差异有统计学意义(P<0.05)。与对照组比较,治疗后治疗组的CIPE-5评分及IELT改善更为明显,差异有统计学意义(P<0.05)。两组患者治疗期间不良事件发生率差异无统计学意义(P>0.05),不良事件可自行缓解。结论:盐酸达泊西汀联合小剂量他达拉非治疗原发性PE安全有效。
Objective：To assess the clinical efficacy of dapoxetine hydrochloride combined with tadalafil at low dosage in the treatment of primary premature ejaculation.Method：Ninety-seven male outpatients with primary premature ejaculation were divided randomly into 2 groups.The control group（46 cases）was only treated with on-demand 30 mg dapoxetine hydrochloride orally before sexual intercourse.The treatment group（51 cases）was treated with dapoxetine hydrochloride in the same way and 5 mg tadalafil orally once a day.All treatments were given for 12 weeks.During the treatment,the patients were required for regular sex no less than 4 times a month,and to make records for CIPE-5 scores and IELT before and after treatment.Result：In both groups,CIPE-5 scores and IELT were improved significantly after treatment（P〈0.05）.However,CIPE-5 scores and IELT of the treatment group were improved more significantly than those of the control group（P〈0.05）.There was no statistical difference in incidence of adverse events between two groups（P〉0.05）,and all of adverse events could be relieved by themselves.Conclusion：The treatment of dapoxetine hydrochloride combined with tadalafil at low dosage is safe and effective for primary premature ejaculation.
作者
邢增术
张冲
刘振湘
白志明
XING Zengshu;ZHANG Chong;LIU Zhenxiang;BAI Zhiming(Department of Urology,Haikou Hospital Affiliated to Xiangya School of Medicine,Central South University,Haikou,570208,China)
出处
《临床泌尿外科杂志》
2018年第8期623-625,632,共4页
Journal of Clinical Urology
关键词
原发性早泄
盐酸达泊西汀
他达拉非
primary premature ejaculation
dapoxetine hydrochloride
tadalafil
